查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1597859

标靶给药系统市场：按产品/应用分类 - 2025-2030 年全球预测

Targeted Drug Delivery System Market by Product, Application (First Order Targeting, Second Order Targeting, Third Order Targeting ) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 180 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年标靶给药系统市值为81.3亿美元，预计2024年将达到96.1亿美元，复合年增长率为18.30%，预计2030年将达到263.8亿美元。

标靶药物输送系统用于製药业，透过将药物特异性引导至作用部位、最大限度地减少全身暴露并减少副作用来提高药物的治疗功效和安全性。其重要性在于其能够改善癌症、糖尿病和心血管疾病等慢性疾病的患者预后。这些系统透过载体抗体、新型聚合物和奈米颗粒等多种机制进行应用，最终用于医院、诊所和研究机构。市场洞察表明，由于慢性病盛行率不断上升、精准医疗的进步以及对个人化治疗解决方案的需求，需求正在激增。主要成长要素包括政府资助、研发投资增加、技术进步。最新的潜在商机在于生技药品、生物相似药和遗传疾病的扩展应用。投资奈米技术并与生物技术公司合作是利用这些机会的策略有效方法。

主要市场统计
基准年[2023] 81.3亿美元
预测年份 [2024] 96.1亿美元
预测年份 [2030] 263.8亿美元
复合年增长率（%） 18.30%

然而，市场面临严格的法律规范、高开发成本和配方复杂性等挑战，阻碍了成长。克服这些障碍需要简化核准流程并创建具有成本效益的开发模型。创新和研究的最佳领域包括生物分解性载体、刺激响应系统和多功能奈米颗粒，它们有望提高靶向能力和生物有效性。我们还可以透过开拓开拓的地理市场并专注于特异性疾病的药物输送机制来推动业务成长。由于市场竞争激烈，技术创新迅速，需要产业参与者持续的技术创新和策略合作来保持竞争力并推动市场扩张。透过专注于开发标靶治疗来解决未满足的医疗需求，并在药物设计中利用人工智慧和机器学习，您可以进一步证明您的业务未来性。

市场动态：快速发展的标靶给药系统市场的关键市场洞察

供需的动态交互作用正在改变标靶给药系统市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时也能帮助企业了解消费行为及其对製造业的影响。

  • 市场驱动因素
    • 世界老年人和儿童人口的成长
    • 对增强药物传递的需求日益增加
    • 政府努力让医疗保健更便利
  • 市场限制因素
    • 靶向药物传输系统的副作用
  • 市场机会
    • 奈米技术的采用增加
    • 生物技术进步开发非侵入性药物传输技术
  • 市场挑战
    • 开发高效能标靶药物传递系统的复杂性

波特五力：开拓标靶给药系统市场的策略工具

波特的五力框架是理解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解对标靶给药系统市场的外部影响

外部宏观环境因素在塑造标靶给药系统市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析 了解目标给药系统市场的竞争格局

对标靶给药系统市场的详细市场占有率分析可以对供应商绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV定位矩阵标靶给药系统市场供应商绩效评估

FPNV 定位矩阵是评估标靶给药系统市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议，以规划靶向给药系统市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，对靶向药物输送系统市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机，并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：对当前市场环境的详细审查、主要企业的广泛资料、对其在市场中的影响力和整体影响力的评估。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 全世界的老年人和儿童人口正在增加。
      • 对增强药物传输系统的需求不断增加
      • 政府努力改善医疗保健的可近性
    • 抑制因素
      • 靶向药物传输系统的副作用
    • 机会
      • 扩大奈米技术的引进
      • 生物技术进步开发非侵入性药物传输技术
    • 任务
      • 开发高效能标靶药物传递系统的复杂性
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章 标靶给药系统市场：副产品

  • 奈米壳
  • 奈米管
  • 奈米线
  • 量子点

第七章标靶给药系统市场：依应用分类

  • 主要标靶化（器官区划）
  • 二次标靶化（细胞标靶化）
  • 三级标靶化（细胞内标靶化）

第八章北美和南美标靶给药系统市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第九章亚太标靶给药系统市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十章欧洲、中东和非洲标靶给药系统市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十一章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • 3M Company
  • AbbVie Inc.
  • Arrowhead Pharmaceuticals, Inc.
  • AstraZeneca PLC
  • Baxter International Inc.
  • Becton, Dickinson and Company
  • Boston Scientific Corporation
  • F. Hoffmann-La Roche Ltd
  • Johnson & Johnson Services, Inc.
  • LUYE PHARMA AG
  • Ocuphire Pharma, Inc.
  • Pfizer Inc.
  • Sanofi SA
  • Savara Inc.
  • Taiwan Liposome Company, Ltd.
Product Code: MRR-4103B31E0A98

The Targeted Drug Delivery System Market was valued at USD 8.13 billion in 2023, expected to reach USD 9.61 billion in 2024, and is projected to grow at a CAGR of 18.30%, to USD 26.38 billion by 2030.

The targeted drug delivery system is a revolutionary approach in the pharmaceutical industry that aims to enhance the therapeutic efficacy and safety of drugs by directing them specifically to the site of action, minimizing systemic exposure, and reducing side effects. Its importance lies in the ability to improve patient outcomes in chronic diseases like cancer, diabetes, and cardiovascular conditions. These systems are applied through various mechanisms such as carrier antibodies, novel polymers, and nanoparticles, and they find end-use across hospitals, clinics, and research institutions. Market insights indicate a burgeoning demand driven by the increasing prevalence of chronic diseases, advancements in precision medicine, and the need for personalized therapeutic solutions. Key growth influencers include government funding, escalating R&D investments, and technological advances. The latest potential opportunities lie in biologics, biosimilars, and expanding applications in genetic disorders. To capitalize on these opportunities, investment in nanotechnology and partnerships with biotech firms can be strategic.

KEY MARKET STATISTICS
Base Year [2023] USD 8.13 billion
Estimated Year [2024] USD 9.61 billion
Forecast Year [2030] USD 26.38 billion
CAGR (%) 18.30%

However, the market faces challenges such as stringent regulatory frameworks, high development costs, and complexities in drug formulation which can impede growth. Overcoming these barriers requires streamlined approval processes and cost-effective development models. The best areas for innovation and research include biodegradable carriers, stimuli-responsive systems, and multifunctional nanoparticles, which promise enhanced targeting capabilities and bioavailability. Business growth can also be driven by exploring unexplored geographic markets and focusing on disease-specific drug delivery mechanisms. The nature of this market is highly competitive and rapidly evolving with continuous technological integration, demanding sustained innovation and strategic collaboration among industry players to maintain a competitive edge and drive market expansion. Emphasizing the development of targeted therapies that address unmet medical needs and leveraging AI and machine learning for drug design can further fortify business prospects.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Targeted Drug Delivery System Market

The Targeted Drug Delivery System Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising geriatric and pediatric population globally
    • Increasing need for enhanced delivery of drug systems
    • Government initiatives to boost healthcare accessibility
  • Market Restraints
    • Adverse effects of targeted drug delivery systems
  • Market Opportunities
    • Increasing adoption of nanotechnology
    • Advances in biotechnology to develop non-invasive drug-delivery technologies
  • Market Challenges
    • Complexity in development of efficient targeted drug-delivery systems

Porter's Five Forces: A Strategic Tool for Navigating the Targeted Drug Delivery System Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Targeted Drug Delivery System Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Targeted Drug Delivery System Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Targeted Drug Delivery System Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Targeted Drug Delivery System Market

A detailed market share analysis in the Targeted Drug Delivery System Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Targeted Drug Delivery System Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Targeted Drug Delivery System Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Targeted Drug Delivery System Market

A strategic analysis of the Targeted Drug Delivery System Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Targeted Drug Delivery System Market, highlighting leading vendors and their innovative profiles. These include 3M Company, AbbVie Inc., Arrowhead Pharmaceuticals, Inc., AstraZeneca PLC, Baxter International Inc., Becton, Dickinson and Company, Boston Scientific Corporation, F. Hoffmann-La Roche Ltd, Johnson & Johnson Services, Inc., LUYE PHARMA AG, Ocuphire Pharma, Inc., Pfizer Inc., Sanofi S.A., Savara Inc., and Taiwan Liposome Company, Ltd..

Market Segmentation & Coverage

This research report categorizes the Targeted Drug Delivery System Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Nano Shells, Nano Tubes, Nano Wires, and Quantum Dots.
  • Based on Application, market is studied across First Order Targeting (Organ Compartmentalization), Second Order Targeting (Cellular Targeting), and Third Order Targeting (Intracellular Targeting).
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising geriatric and pediatric population globally
      • 5.1.1.2. Increasing need for enhanced delivery of drug systems
      • 5.1.1.3. Government initiatives to boost healthcare accessibility
    • 5.1.2. Restraints
      • 5.1.2.1. Adverse effects of targeted drug delivery systems
    • 5.1.3. Opportunities
      • 5.1.3.1. Increasing adoption of nanotechnology
      • 5.1.3.2. Advances in biotechnology to develop non-invasive drug-delivery technologies
    • 5.1.4. Challenges
      • 5.1.4.1. Complexity in development of efficient targeted drug-delivery systems
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Targeted Drug Delivery System Market, by Product

  • 6.1. Introduction
  • 6.2. Nano Shells
  • 6.3. Nano Tubes
  • 6.4. Nano Wires
  • 6.5. Quantum Dots

7. Targeted Drug Delivery System Market, by Application

  • 7.1. Introduction
  • 7.2. First Order Targeting (Organ Compartmentalization)
  • 7.3. Second Order Targeting (Cellular Targeting)
  • 7.4. Third Order Targeting (Intracellular Targeting)

8. Americas Targeted Drug Delivery System Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Targeted Drug Delivery System Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Targeted Drug Delivery System Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. 3M Company
  • 2. AbbVie Inc.
  • 3. Arrowhead Pharmaceuticals, Inc.
  • 4. AstraZeneca PLC
  • 5. Baxter International Inc.
  • 6. Becton, Dickinson and Company
  • 7. Boston Scientific Corporation
  • 8. F. Hoffmann-La Roche Ltd
  • 9. Johnson & Johnson Services, Inc.
  • 10. LUYE PHARMA AG
  • 11. Ocuphire Pharma, Inc.
  • 12. Pfizer Inc.
  • 13. Sanofi S.A.
  • 14. Savara Inc.
  • 15. Taiwan Liposome Company, Ltd.

LIST OF FIGURES

  • FIGURE 1. TARGETED DRUG DELIVERY SYSTEM MARKET RESEARCH PROCESS
  • FIGURE 2. TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. TARGETED DRUG DELIVERY SYSTEM MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. TARGETED DRUG DELIVERY SYSTEM MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. TARGETED DRUG DELIVERY SYSTEM MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. TARGETED DRUG DELIVERY SYSTEM MARKET DYNAMICS
  • TABLE 7. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY NANO SHELLS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY NANO TUBES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY NANO WIRES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY QUANTUM DOTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY FIRST ORDER TARGETING (ORGAN COMPARTMENTALIZATION), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY SECOND ORDER TARGETING (CELLULAR TARGETING), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY THIRD ORDER TARGETING (INTRACELLULAR TARGETING), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. AMERICAS TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 17. AMERICAS TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 18. AMERICAS TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 19. ARGENTINA TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 20. ARGENTINA TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 21. BRAZIL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 22. BRAZIL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 23. CANADA TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 24. CANADA TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 25. MEXICO TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 26. MEXICO TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 27. UNITED STATES TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 28. UNITED STATES TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 29. UNITED STATES TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 30. ASIA-PACIFIC TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 31. ASIA-PACIFIC TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 32. ASIA-PACIFIC TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 33. AUSTRALIA TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 34. AUSTRALIA TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 35. CHINA TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 36. CHINA TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 37. INDIA TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 38. INDIA TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 39. INDONESIA TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 40. INDONESIA TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 41. JAPAN TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 42. JAPAN TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 43. MALAYSIA TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 44. MALAYSIA TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 45. PHILIPPINES TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 46. PHILIPPINES TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 47. SINGAPORE TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 48. SINGAPORE TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 49. SOUTH KOREA TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 50. SOUTH KOREA TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 51. TAIWAN TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 52. TAIWAN TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 53. THAILAND TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 54. THAILAND TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 55. VIETNAM TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 56. VIETNAM TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 57. EUROPE, MIDDLE EAST & AFRICA TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 58. EUROPE, MIDDLE EAST & AFRICA TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 59. EUROPE, MIDDLE EAST & AFRICA TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 60. DENMARK TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 61. DENMARK TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 62. EGYPT TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 63. EGYPT TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 64. FINLAND TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 65. FINLAND TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 66. FRANCE TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 67. FRANCE TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 68. GERMANY TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 69. GERMANY TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 70. ISRAEL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 71. ISRAEL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 72. ITALY TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 73. ITALY TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 74. NETHERLANDS TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 75. NETHERLANDS TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 76. NIGERIA TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 77. NIGERIA TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 78. NORWAY TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 79. NORWAY TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 80. POLAND TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 81. POLAND TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 82. QATAR TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 83. QATAR TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 84. RUSSIA TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 85. RUSSIA TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 86. SAUDI ARABIA TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 87. SAUDI ARABIA TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH AFRICA TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 89. SOUTH AFRICA TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 90. SPAIN TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 91. SPAIN TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 92. SWEDEN TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 93. SWEDEN TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 94. SWITZERLAND TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 95. SWITZERLAND TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 96. TURKEY TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 97. TURKEY TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 98. UNITED ARAB EMIRATES TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 99. UNITED ARAB EMIRATES TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 100. UNITED KINGDOM TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 101. UNITED KINGDOM TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 102. TARGETED DRUG DELIVERY SYSTEM MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 103. TARGETED DRUG DELIVERY SYSTEM MARKET, FPNV POSITIONING MATRIX, 2023